The Rutgers Cancer Institute of New Jersey announced it has begun a clinical trial that will examine whether an anti-malaria drug doctors are administering as an off-label use to treat the coronavirus is more effective when taken with an antibiotic. Clinical trials take year to complete. But Rutgers, a nationally recognized comprehensive cancer center, has the in-house expertise to move faster, said Rutgers Cancer Institute Director Steven K. Libutti, who is overseeing the trial. To read the full article.
- Child Health Institute Science Seminar on February 26th at 1pm
- Rutgers Health and RWJBarnabas Health Receive Grant to Train Health Professionals and Improve Care
- Register Now for Rutgers Health Anniversary Symposium on March 20th
- New NJACTS Publication
- Study Charts Possibilities for a Better Way to Diagnose Gestational Diabetes.